February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib – Medicines Patent Pool
Jun 22, 2023, 18:35

Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib – Medicines Patent Pool

Breaking | 4 generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis,’ nilotinib for the treatment of chronic myeloid leukaemia.
The four generic manufacturers companies include:

  1. Eugia Pharma Specialities Ltd (INDIA)
  2. Hetero (INDIA)
  3. Dr. Reddy’s Laboratories (INDIA)
  4. PT. Brightgene Biomedical Indonesia (INDONESIA)

 

Source: /Linkedin